rs201490017
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001376256.1(CRYM):c.343A>G(p.Ile115Val) variant causes a missense change. The variant allele was found at a frequency of 0.00104 in 1,614,102 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001376256.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000598 AC: 91AN: 152236Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00207 AC: 520AN: 251412Hom.: 6 AF XY: 0.00294 AC XY: 400AN XY: 135876
GnomAD4 exome AF: 0.00108 AC: 1585AN: 1461748Hom.: 28 Cov.: 30 AF XY: 0.00158 AC XY: 1151AN XY: 727174
GnomAD4 genome AF: 0.000591 AC: 90AN: 152354Hom.: 2 Cov.: 33 AF XY: 0.000886 AC XY: 66AN XY: 74504
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Ile115Val varia nt in CRYM has not been previously reported in individuals with hearing loss, bu t has been identified in 0.01% (1/8600) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu; dbSNP rs201490017) . Computational analyses (biochemical amino acid properties, conservation, Alig nGVGD, PolyPhen2, and SIFT) suggest this variant may not impact the protein, tho ugh this information is not predictive enough to rule out pathogenicity. In summ ary, the clinical significance of this variant cannot be determined with certain ty; however, based upon the computational data we lean towards a more likely ben ign role. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at